Introduction
Human papillomaviruses (HPV) are double-stranded DNA viruses that infect mucosal or cutaneous epithelial tissues (Bravo and FelezSanchez, 2015) . The mucosotropic low-risk types cause benign anogenital warts and recurrent respiratory papillomatosis, whereas persistent infections by high-risk HPVs can progress to cancers. Over 95% of cervical cancers (Walboomers et al., 1999) , 70% of oropharyngeal cancers and about 5-30% of other head and neck carcinomas are caused by high-risk HPVs (Prigge et al., 2017) . In 2012, 266,000 deaths worldwide resulted from 530,000 cases of cervical carcinomas (Ferlay et al., 2015) . Prophylactic vaccines (Gardasil, Gardasil-9 and Cervarix) are highly effective, but they are type-restricted and do not impact preexisting infections (Schiller and Muller, 2015) . Moreover, HPV vaccination programs around the world have been met with varied acceptability (Bruni et al., 2016) . Importantly, there are no pharmaceutical agents that reliably and efficaciously treat HPV infections by specifically targeting viral DNA amplification and persistence.
All HPV genotypes establish infection in basal keratinocytes of a squamous epithelium, where extrachromosomal viral genomes are maintained as low copy number plasmids with minimal early gene expression in order to dodge immune surveillance. In active infections, elevated viral RNA transcription and DNA amplification occur in the differentiating epithelium (Chow et al., 2010; Doorbar et al., 2015; Stoler et al., 1989) . Three dimensional (3D) organotypic (raft) cultures of PHKs recapitulate the proliferation and differentiation of a squamous epithelium and support virus production in explanted warty lesions Wilson et al., 1992) . By utilizing the Cre-LoxP recombination, high titers of infectious HPV-18 virus are produced in raft cultures of PHKs transfected with recombinant HPV-18 plasmids. In situ analyses of these cultures have produced molecular details of the viral productive program ). The HPV-16 and HPV-31 life cycles have also been studied in raft cultures of immortalized NIKS cell lines or in human foreskin keratinocytes after prolonged passaging (Lambert et al., 2005; Wilson et al., 2005) , but viral DNA amplification was not as robust.
Papillomaviral DNA replication requires the viral E2 and E1 proteins. E2 binds to the replication origin and helps recruit the replicative DNA helicase E1. The host supplies all other replication proteins and substrates (Kuo et al., 1994) . To enable viral DNA amplification in differentiated cells, HPV oncoproteins E6 and E7 destabilize the major tumor suppressors, p53 and the pRB family proteins, respectively Galloway and Laimins, 2015) . E7 protein reactivates the cell cycle genes and S-phase reentry (Cheng et al., 1995; Genovese et al., 2008) along with the DNA damage response (DDR) (Banerjee et al., 2011; Hong and Laimins, 2013; Moody and Laimins, 2009 ). Subsequent to S-phase, the differentiated cells transition into a prolonged G2-phase, during which the viral genome amplifies (Banerjee et al., 2011; Wang et al., 2009 ). Prolonged G2 is evidenced by suprabasal accumulation of cytoplasmic cyclin B1. Kinases activated by DDR stabilize p53, which, in turn, is inactivated or destabilized by E6 in association with E6-AP. This E6 function is critical for efficient viral DNA amplification (Kho et al., 2013; Wang et al., 2009) . Following viral DNA amplification, E7 activity wanes and becomes extinguished, as deduced from the cessation of cellular DNA replication and the loss of cyclin B1. Viral transcription then switches to late gene expression, producing capsid proteins for progeny virion assembly. Thus, biomarkers for HPV E7 activity include induction of suprabasal proliferating cell nuclear antigen (PCNA), suprabasal bromodeoxyuridine (BrdU) incorporation into replicating host DNA, and accumulation of suprabasal cytoplasmic cyclin B1, whereas p53 accumulation is a marker for reduced E6 function.
Acyclic nucleoside analogs have been developed to inhibit the replication of diverse virus families (De Clercq, 2003a; De Clercq and Li, 2016) . For example, (S)-1-[(3-hydroxy-2-phosphonomethoxy) propyl] cytosine (HPMPC, i.e., Cidofovir (CDV)) has a 100-500 fold higher affinity for human cytomegalovirus (CMV) DNA polymerases than for cellular DNA polymerases (Hitchcock et al., 1996; Kramata and Downey, 1999) and is effective in treating CMV retinitis (De Clercq, 2003b) . HPVs do not encode a DNA polymerase, but CDV has been used to treat preneoplastic HPV infections of mucosal epithelia with mixed results (De Clercq, 2003a, b; Stier et al., 2013; Van Pachterbeke et al., 2009) . The bioavailability of CDV is low, and delivery of high concentrations over long durations may cause systemic toxicity and renal failure (Bienvenu et al., 2002) . Importantly, the efficacy of CDV in blocking productive HPV DNA amplification or viral persistence has not been critically examined.
Lipid esters of acyclic nucleoside phosphonate antivirals show greatly increased cell uptake and antiviral activity (Hostetler, 2009) . Octadecyloxyethyl benzyl 9-[(2-phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG, i.e., ABI-1968 ) is a diester of the acyclic guanine-based phosphonate. Benzyl diesters exhibit very slow intracellular conversion to the active diphosphate metabolite, providing sustained effects (Andrei et al., 2015; Beadle et al., 2016) . Because it lacks a 3' hydroxyl, DNA chain elongation ceases following PMEG incorporation. It effectively inhibits HPV origin-dependent plasmid amplification in transfected HEK-293 cells (Beadle et al., 2016) . In the present study, we investigated ODE-Bn-PMEG as a prodrug inhibitor of HPV-18 genomic DNA amplification in organotypic epithelial cultures. This 3D raft culture is a highly informative model well suited to reveal the mechanisms of action and possible side effects in uninfected tissues. We demonstrate that ODE-Bn-PMEG at 1.5 μM has superior antiviral effects relative to 15 μM CDV. ODE-Bn-PMEG blocks HPV DNA amplification, virion production and possibly viral persistence, as well as causing apoptosis in suprabasal infected cells.
Materials and methods
PHKs were isolated from circumcised neonatal foreskins with approval by the UAB Institutional Review Board. Raft cultures of PHKs with or without HPV-18 genomic plasmid were prepared as described ). ODE-Bn-PMEG (HPLC purity = 94.6%) was synthesized as described (Beadle et al., 2016) . 10 mM stock solution of ODE-Bn-PMEG or CDV in DMSO was added to the cultures to final concentrations and for durations indicated for each experiment. Raft cultures were harvested, fixed in 10% buffered formalin and embedded in paraffin. Four micron sections were used for in situ assays. Unfixed tissues were used to determine viral DNA copy number per cell. Detailed protocols and reagents are provided in Fig. 2 . Inhibitory effects of ODE-Bn-PMEG and Cidofovir on cellular DNA replication in HPV-18 raft cultures. (A) Histology (upper row) and IHC for BrdU incorporation (reddish-brown in the lower row) in HPV-18 raft cultures unexposed or exposed to 15 μM CDV from day 6 to day 14 or to ODE-Bn-PMEG at 1.5 μM from day 6 to day 10 or 14. (B) Histology (upper row) and IHC for BrdU incorporation (lower row) in uninfected PHK raft cultures unexposed or exposed to 15 μM CDV from day 6 to day 14 or to 1.5 μM ODE-Bn-PMEG from day 6 to day 10 or 14. All cultures were harvested on day 14. Images were captured with 20× objective. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Supplementary Materials (Appendix A).
Results

ODE-Bn-PMEG inhibited HPV-18 DNA amplification and cellular DNA replication
HPV-18 DNA amplification takes place between day 10 and day 14 after the cultures are placed at the liquid medium-air interface ). In uninfected cultures, S phase cells, as indicated by BrdU incorporation into replicating host cell DNA, were observed only in the basal stratum. Untreated HPV-18 raft cultures were hyperplastic relative to uninfected cultures (Fig. 1A) , and stochastic suprabasal Sphase reentry was induced in a substantial fraction of the differentiated cells (Fig. 1B) . Based on previous results (Beadle et al., 2016) and the toxicity in submerged PHK cultures, a subset of the cultures was treated with ODE-Bn-PMEG at 0.16 μM, 0.5 μM or 1.5 μM. Application started on day 6 (refreshed on days 8, 10 and 12) and cultures were harvested on day 13. Upon exposure to 0.5 μM and 1.5 μM, uninfected and HPV-infected cultures became thinner than the untreated cultures, with decreasing DAPI-positive nuclei ( Fig. 1A and B). In uninfected raft cultures, BrdU-positive basal nuclei were virtually abolished, suggestive of a cytostatic effect. In the infected cultures, positive nuclei and the signal intensity were both greatly reduced (Fig. 1A , C, see also Fig. S1B ). Real time qPCR in three independent experiments conducted with separate batches of PHKs revealed a concentration-dependent decrease in viral DNA copy numbers per cell, down to about 20% of those in untreated control cultures (Fig. 1D) . Fluorescence in situ hybridization to HPV DNA in tissue sections supported this conclusion (Fig. 1E) .
The durable antiviral effect of ODE-Bn-PMEG
To test the durability of ODE-Bn-PMEG, we exposed normal and HPV-18 infected raft cultures to 1.5 μM ODE-Bn-PMEG over days 6-10 (applied on days 6 and 8), days 6-12 (applied on days 6, 8, and 10), or days 6-14 (applied on day 6, 8, 10, and 12). One set of cultures was harvested on day 14 and another set on day 18. Compound-treated day 14 HPV-18 and normal cultures were thinner than untreated control cultures, and BrdU-positive cells were greatly reduced (Fig. 2, Fig. S1B ), in agreement with the previous experiments (Fig. 1A) . Importantly, neither culture recovered after additional days of culturing in compound-free media (Fig. 2, Fig. S1B ). These results indicate a durable inhibition, consistent with the slow conversion of ODE-Bn-PMEG to a DNA replication substrate in human fibroblasts (Beadle et al., 2016) . In addition, chain termination would preclude further elongation during the chase. In this series of experiments, we observed suprabasal condensed nuclei in the infected cultures, suggestive of apoptosis ( Fig. 2A) .
Real Time qPCR revealed that untreated HPV-18 infected cultures harbored 5000 and 4000 copies/cell on days 14 and 18, respectively. In samples exposed to ODE-Bn-PMEG for 4 days or longer, viral DNA was reduced by more than 90%. Viral DNA amplification did not rebound after a chase with compound-free medium (Fig. 3A) . Indeed, FISH detected sparingly few cells with amplified HPV DNA upon short or long exposure ( Fig. 3B and C) . The capsid L1 protein was not detected in treated day 18 cultures, consistent with the dependency of L1 expression on high viral DNA amplification (Kho et al., 2013; Wang et al., 2009) (Fig. 3D). 3.3. ODE-Bn-PMEG significantly reduced E7-mediated induction of PCNA and cyclin B1
The absence of suprabasal BrdU incorporation does not necessarily indicate the absence of the viral genome. We probed the tissues for the well-established E7-induced biomarkers PCNA and cyclin B1 for evidence of persisting viral activities. Indirect IF assays showed that ODEBn-PMEG reduced basal PCNA and cyclin B1 in infected and uninfected cultures (Fig. 4, Fig. S1A ). In the infected cultures, a greater reduction of suprabasal signals was observed in cultures exposed over days 6-14 than those exposed over days 6-10. In day 14 cultures, suprabasal viral activity was still evident (Fig. S2, rows 4 and 5) . However, in cultures harvested on day 18, only very few basal cells were weakly positive for these two biomarkers (Fig. 4, rows 4 and 5) . The patterns and signal intensities resembled those in normal PHK raft cultures (Fig. 4 , compare rows 1 to 5), suggesting that ODE-Bn-PMEG effectively abrogated E7 activities.
3.4. ODE-Bn-PMEG induced DNA damage in HPV-18 raft cultures γ-H2AX is a marker for double-stranded DNA breaks (Rogakou et al., 1998) . Indirect IF assays detected signals primarily in suprabasal cells of HPV-18 cultures treated with 1.5 μM ODE-Bn-PMEG (Fig. 5A) . The percentage of positive nuclei increased from 30% to over 50% of total nuclei, with increasing duration of exposures (Fig. 5B) . This percentage did not decrease following a 4-day chase in day 18 cultures. By comparison, nuclei positive for γ-H2AX were detected only in 1 or 2 per 100 cells in the untreated HPV-18 raft cultures. Untreated normal PHK cultures had no signal, but positive nuclei were detected in treated cultures (Fig. 5A ). Thus replicating DNA is vulnerable to this inhibitor irrespective of infection, but infected cultures accumulate more γ-H2AX-positive nuclei due to the high numbers of suprabasal cells in Sphase.
ODE-Bn-PMEG induced apoptosis in HPV-18 raft cultures
The high percentage of γ-H2AX positive nuclei and incidence of condensed nuclei in HPV-18 raft cultures exposed to ODE-Bn-PMEG (Figs. 2 and 5) are suggestive of apoptosis. Positive TUNEL signals indicative of extensive DNA fragmentation and cell death indeed detected in infected cultures harvested on day 14, but primarily in the differentiated strata. Positive nuclei increased with a higher concentration and longer duration of exposure ( Fig. 6A and B, see also Fig. S3 ).
The cell number and hence thickness of uninfected raft cultures normally decrease with age as basal cell proliferation diminishes. Infected raft cultures also became thinner because of reduced basal cell proliferation and reduced HPV early gene expression following viral DNA amplification (Fig. 6C , compare total nuclei in untreated HPV-18 cultures harvested on day18 and day 14). In day 14 and day 18 infected cultures exposed to 1.5 μM ODE-Bn-PMEG, DAPIpositive nuclei were reduced to about 20%-30% of untreated cultures of the same age (Fig. 6C) . These results are consistent with reduced basal cell proliferation, continued loss of apoptotic cells, or both.
In contrast, TUNEL-positive nuclei were rarely detected in control or PHK cultures exposed to 1.5 μM ODE-Bn-PMEG for various durations (Fig. 6A, top row) . Along with the loss of basal BrdU incorporation, these results suggest that 1.5 μM ODE-Bn-PMEG is largely cytostatic to normal PHK raft cultures.
3.6. Cidofovir (CDV) reduced HPV DNA amplification but did not significantly affect viral activity CDV at 6 μM reduced the titer of camel pox virus (CML1) in PHK raft cultures by 99% (Duraffour et al., 2007) . However, it had little effect on HPV ori-dependent plasmid amplification in transiently transfected HEK-293 cells (Beadle et al., 2016) . In parallel to the time course experiments just described, we also examined normal and HPV-18 infected day 14 and day 18 raft cultures after an exposure to 15 μM CDV over days 6-14. CDV reduced viral DNA amplification, but not as effectively as ODE-Bn-PMEG (Fig. 3A) . L1 expression was abolished (Fig. 3D) . The tissues were slightly thinner ( Fig. 2A) and contained fewer DAPI-positive cells than controls, but twice as many as in ODEBn-PMEG exposed cultures (Fig. 6C) . However, suprabasal BrdU-(caption on next page) N.S. Banerjee et al. Antiviral Research 150 (2018) [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] positive cell numbers did not appear to change significantly ( Fig. 2 and Fig. S4 ). The suprabasal cells also remained positive for PCNA and cyclin B1 (Fig. 4 and Fig. S2 ). These observations demonstrate that, despite reduced HPV-18 plasmid amplification, transcriptionally competent viral genomes persisted. In contrast, in uninfected PHK cultures, Cidofovir inhibited BrdU incorporation and eliminated cyclin B1 signal in basal cells (Fig. S1B ), indicative of a cytostatic effect in normal raft cultures.
In the infected cultures, CDV exposure induced γ-H2AX-positive nuclei, but the number was significantly lower than cultures treated with 1.5 μM ODE-Bn-PMEG (Fig. 5A and B) . The DNA damage appeared to be transient or not extensive, as the cultures exhibited no condensed nuclei characteristic of apoptosis (Fig. 2) and were virtually negative for TUNEL signals (Fig. 6A and B) . Thus, CDV reduced the cell number to 48% of the untreated control (Fig. 6C) , largely due to the inhibition of basal cell proliferation. The differential cell number relative to ODEBn-PMEG treated cultures could be attributed to the absence of TUNELpositive apoptosis in CDV-treated cultures ( Fig. 6A and B) . In normal PHK raft cultures, CDV induced few if any γ-H2AX-positive or TUNELpositive nuclei (Figs. 5 and 6 ).
Cidofovir stabilized p53 to inhibit HPV-18 DNA amplification
Why did CDV exposure (days 6-14) reduce HPV-18 DNA amplification by 80% (Fig. 3A) , while the E7 activity was hardly affected (Fig. 4 and Fig. S2 )? We previously demonstrated that E6 mutants that are unable to destabilize p53 do not amplify viral DNA to high copy numbers (Kho et al., 2013; Wang et al., 2009) . Double IF was performed in inhibitor-treated HPV-18 raft cultures. While control cultures had cyclin B1 signal but no p53 signal, both p53 and cyclin B1 were detected in CDV-treated (Fig. 7) . In contrast, in ODE-Bn-PMEG treated cultures, neither p53 nor cyclin B1 was detected (Fig. 7, 3rd and 4th Fig. 3 . Short exposure to ODE-Bn-PMEG induced durable inhibition of HPV-18 DNA amplification. (A) Relative HPV-18 DNA copy numbers per cell were determined by quantitative real time PCR in raft cultures exposed to CDV (day 6 to day 14) or to ODE-Bn-PMEG (from day 6 to day 10, 12 or 14). Cultures were harvested on day 14 or day 18. HPV-18 DNA was not detected in raft cultures exposed to the inhibitor from day 6 to day 12 or day 6 to day 14 and harvested on day 18. (B) HPV-18 plasmid amplification was detected by FISH in HPV-18 raft cultures unexposed (left panel) or exposed to ODE-Bn-PMEG from day 6 to day 10 (middle panel) or from day 6 to day 14 (right panel). All cultures were harvested on day 14. HPV DNA failed to recover and amplify during the 4 days of drug-free chase (middle panel). (C) Quantitative estimates of HPV-18 DNA positive nuclei averaged from four images in each treatment. Error bars indicate standard deviation and '***' indicate p value < .005. (D) IHC detection of the L1 capsid protein (reddish-brown) in control or treated HPV-18 raft cultures on day 18. Images were captured with 20× objective. Fig. 4 . In situ assays for biomarkers of HPV infection. PCNA (red, left panels) and cyclin B1 (green, middle panels), merged along with DAPI nuclear stain (blue, right panels) were detected by indirect IF microscopy in raft cultures harvested on day 18. Images are shown for untreated PHK culture (top row), untreated HPV-18 culture (row 2), and HPV-18 cultures exposed to 15 μM CDV from day 6 to day 14 (row 3), or to 1.5 μM ODE-Bn-PMEG from day 6 to day 10 (row 4) and from day 6 to day 14 (row 5). Images were captured with 20× objective. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) rows from top), in agreement with a loss of the E7 activity. Normally the expression of E7 in raft cultures causes p53 stabilization in the absence of E6 (Jian et al., 1998) .
Discussion
In this study, we investigated the efficacy of ODE-Bn-PMEG as an anti-HPV agent in a 3D organotypic model system prepared from PHKs containing HPV-18 genomic plasmid. Our results reveal that the compound is effective and durable in abrogating viral DNA amplification and virus production. This antiviral effect is attributable to obligate chain termination during cellular and viral DNA replication. A high efficacy was reached at 1.5 μM after an exposure for 8 days (days 6-14). Viral DNA copy numbers/cell were reduced by at least 90%. We further conclude that suprabasal viral DNA was rendered transcriptionally inactive, as the induction of PCNA, suprabasal BrdU incorporation, and cytoplasmic cyclin B1 accumulation, all biomarkers of E7 activity (Banerjee et al., 2011) , were dramatically reduced (Fig. 4 and Fig. S2 ). These results are expected, as transcription takes place only on supercoiled templates. Replication intermediates trapped by chain termination or broken into fragments are not effective templates. Incomplete viral genomes are also subject to destruction by nucleases. In fact, in the day 18 cultures after a 8-day treatment and 4-day chase, the basal cells of infected cultures resembled those in uninfected cultures when probed for PCNA or cyclin B1 (Fig. 4) . These results suggest the possibility that at least some of the basal cells had lost viral activity, if not viral DNA. Since all HPVs use the same mechanisms to amplify their DNA in the differentiated cells, these inhibitory effects are expected to extend to other HPV genotypes.
Our results agree with the evidence that ODE-Bn-PMEG and its active metabolite PMEG-pp have a long intracellular stability (14 days after a 48 h exposure) in human fibroblasts (Beadle et al., 2016) . Cellular DNA replication and viral DNA amplification did not rebound after a chase of 4-8 days (day 14 or day 18 cultures after an exposure on days 6-10, 6-12 or 6-14), as judged from multiple biomarkers. These results imply that DNA damage was not repaired, consistent with a lack of reduction in γ-H2AX positive nuclei during the chase. Consequently, extensive apoptosis took place in the suprabasal differentiated strata. Chain termination after the incorporation of ODE-Bn-PMEG metabolite also interferes with basal cell DNA replication and cell division of infected or uninfected cultures. Despite the cytostatic effect in uninfected basal cells, 1.5 μM ODE-Bn-PMEG rarely caused apoptosis. We suggest that, relative to basal cells, infected suprabasal cells are sensitized to cytotoxic effects of ODE-Bn-PMEG due to elevated viral E7 gene activities. For instance, S-phase genes, including PCNA (Fig. 4 and Fig. S2 ) and the p180 catalytic subunit of DNA polymerase α (Chien et al., 2000) , are expressed to higher levels in the differentiated cells as compared to the basal cells.
We further treated raft cultures with 2.5 μM of ODE-Bn-PMEG for various durations, with or without a chase. Viral DNA copy number per . TUNEL assay to detect apoptosis. (A) Apoptotic nuclei (green) were revealed by TUNEL assay in uninfected and HPV-18 infected raft cultures. Cultures were unexposed (control) or exposed to 1.5 μM ODE-Bn-PMEG from day 6 to day 10 or 14, or to 15 μM CDV from day 6-14 and harvested on day 14 or day 18. Nuclei were stained with DAPI. (B) Percentages of TUNEL-positive nuclei relative to total nuclei were determined using counts from 4 different microscopic fields for each treatment of the HPV-18 raft cultures. (C) Average numbers of DAPI stained nuclei per microscopic field were counted in HPV-18 raft cultures. Images were captured with 20× objective. Error bar indicate standard deviation. '**' and '***' indicate p value < .05 and < 0.005. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Fig. 7 . Fluorescence microscopy to detect p53 (red), cyclin B1 (green) and DAPI in HPV-18 raft cultures. Day 18 control, untreated cultures (top row), cultures exposed to 15 μM CDV from day 6 to day 14 (row 2), or to 1.5 μM ODE-Bn-PMEG from day 6 to day 10 (row 3) and from day 6 to day 14 (row 4). Digitally enlarged views of two areas (L and R) from the CDVtreated raft culture (row 2) reveal stabilization of p53 in the nuclei of cells with cytoplasmic cyclin B1. Images were captured with 20× objective. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) N.S. Banerjee et al. Antiviral Research 150 (2018) [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] cell was further reduced (Fig. 3A) . However, apoptosis was induced in both infected and uninfected raft cultures ( Fig. S3A and B) . Thus the selectivity of infected over uninfected cultures was diminished or lost at this high concentration. We also examined the effects of CDV, which has been used for clinical treatment of infections with a variety of DNA viruses, including HPV-induced warts, condyloma and laryngeal papillomas. The results were mixed (Andrei et al., 2000; De Clercq, 2003a, b) . In our model system, CDV at 15 μM reduced viral DNA amplification and induced DNA damage. However, it induced very little or no apoptosis and did not reduce viral E7 activity. These observations are consistent with the notion that CDV is not an obligate chain terminator and is inefficiently incorporated into DNA by cellular DNA polymerases (Wolfgang et al., 2009) . Interestingly, while E7 activity persisted, E6 activity with regard to p53 destabilization was somewhat compromised. Thus, the stabilized p53 could be responsible in part for the reduced HPV-18 DNA amplification. Previous reports indicated that CDV induced p53 stabilization in HPV-positive cervical cancer cell lines (Abdulkarim et al., 2002; Andrei et al., 2000; Sirianni et al., 2005) , but the mechanism was unknown. Abdulkarim et al. (2002) also reported that CDV reduced E7 protein and increased pRb in these cells. Although we cannot rule out that E7 activity was also diminished in CDV-treated cultures, our probing for surrogate biomarkers of E7 activities such as S-phase reentry (BrdU incorporation), PCNA induction, and cytoplasmic cyclin B1 accumulation strongly indicate that significant E7 activity persisted in CDV-treated raft cultures (Figs. 4 and 7, Figs. S2 and S4) .
Conclusions
ODE-Bn-PMEG (ABI-1968) is superior to Cidofovir as an inhibitor of pre-neoplastic HPV infection, abolishing viral DNA amplification and production of progeny virus. Furthermore, it causes apoptosis in suprabasal infected keratinocytes while sparing uninfected cultures. ODEBn-PMEG is a very promising antiviral candidate for additional preclinical development leading to clinical trials.
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